JF
Jump Financial Portfolio holdings
AUM
$8.14B
1-Year Return
18.67%
This Quarter Return
+4.69%
1 Year Return
+18.67%
3 Year Return
+54.31%
5 Year Return
+107.56%
10 Year Return
–
AUM
$4.76B
AUM Growth
-$118M
(-2.4%)
Cap. Flow
-$366M
Cap. Flow
% of AUM
-7.68%
Top 10 Holdings %
Top 10 Hldgs %
11.26%
Holding
2,112
New
511
Increased
519
Reduced
515
Closed
521
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$93.6M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$84.2M |
| 3 |
Amazon
AMZN
|
+$28.8M |
| 4 |
Broadcom
AVGO
|
+$25.8M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$23.9M |
Top Sells
| 1 |
SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$163M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$156M |
| 3 |
POSCO
PKX
|
+$119M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$51.8M |
| 5 |
Palantir
PLTR
|
+$47.8M |
Sector Composition
| 1 | Technology | 17.6% |
| 2 | Consumer Discretionary | 12.72% |
| 3 | Financials | 11.5% |
| 4 | Industrials | 11.27% |
| 5 | Healthcare | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
iShares 7-10 Year Treasury Bond ETF
IEF
$36.1B
| $2.9M | 0.06% |
31,361
-5,370
| -15% | -$496K |
|
377
NOV
NOV
$4.87B
| $2.9M | 0.06% |
198,471
+172,101
| +653% | +$2.51M |
|
|
SUPV
378
Grupo Supervielle
SUPV
$538M
| $2.88M | 0.06% |
190,813
+14,082
| +8% | +$213K |
|
379
DoubleVerify
DV
$2.28B
| $2.88M | 0.06% |
149,800
-163,133
| -52% | -$3.13M |
|
380
Essex Property Trust
ESS
$17.4B
| $2.87M | 0.06% |
10,051
-25,391
| -72% | -$7.25M |
|
381
Olin
OLN
$2.95B
| $2.87M | 0.06% |
84,791
-22,282
| -21% | -$753K |
|
382
Nova
NVMI
$8.15B
| $2.86M | 0.06% |
14,542
+242
| +2% | +$47.7K |
|
383
Franklin Resources
BEN
$12.8B
| $2.86M | 0.06% |
141,048
-27,517
| -16% | -$558K |
|
384
Aspen Aerogels
ASPN
$545M
| $2.85M | 0.06% |
239,895
+141,795
| +145% | +$1.68M |
|
385
Otis Worldwide
OTIS
$34.6B
| $2.84M | 0.06% |
+30,637
| New | +$2.84M |
|
386
PTC Therapeutics
PTCT
$4.63B
| $2.84M | 0.06% |
+62,809
| New | +$2.84M |
|
|
XIFR
387
XPLR Infrastructure, LP
XIFR
$929M
| $2.83M | 0.06% |
159,086
+14,486
| +10% | +$258K |
|
388
Popular Inc
BPOP
$8.42B
| $2.83M | 0.06% |
30,100
+4,419
| +17% | +$416K |
|
|
LX
389
LexinFintech Holdings
LX
$1.01B
| $2.83M | 0.06% |
+488,112
| New | +$2.83M |
|
390
Acadia Pharmaceuticals
ACAD
$4.13B
| $2.83M | 0.06% |
154,006
-12,382
| -7% | -$227K |
|
391
Adient
ADNT
$1.89B
| $2.82M | 0.06% |
163,729
+134,729
| +465% | +$2.32M |
|
392
Nu Holdings
NU
$75.7B
| $2.8M | 0.06% |
269,807
+184,561
| +217% | +$1.91M |
|
393
VeriSign
VRSN
$26.9B
| $2.78M | 0.06% |
13,453
-1,814
| -12% | -$375K |
|
394
Avidity Biosciences
RNA
$6.15B
| $2.78M | 0.06% |
+95,575
| New | +$2.78M |
|
395
Corning
GLW
$63.3B
| $2.76M | 0.06% |
58,166
+33,095
| +132% | +$1.57M |
|
396
UFP Technologies
UFPT
$1.55B
| $2.76M | 0.06% |
+11,299
| New | +$2.76M |
|
397
Hamilton Lane
HLNE
$6.58B
| $2.74M | 0.06% |
+18,488
| New | +$2.74M |
|
398
Nuvalent
NUVL
$5.67B
| $2.74M | 0.06% |
34,948
+5,163
| +17% | +$404K |
|
399
Charles River Laboratories
CRL
$7.72B
| $2.73M | 0.06% |
+14,794
| New | +$2.73M |
|
400
Regions Financial
RF
$24B
| $2.72M | 0.06% |
+115,712
| New | +$2.72M |
|